Menu

AstraZeneca argued that Vermont's 340B contract pharmacy access law "precludes manufacturers like AstraZeneca from participating" in HRSA's 340B rebate pilot.

AstraZeneca Sues Vermont Over 340B Contract Pharmacy Access Law, Argues It Precludes Rebate Pilot Participation

November 12, 2025 William Newton, Associate Editor/Senior Writer 340B Report Views

U.K.-based pharmaceutical giant AstraZeneca recently filed the second drug industry lawsuit challenging Vermont’s 340B contract pharmacy access law. AstraZeneca’s Nov. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

PhRMA Again Targets 340B Hospitals, PBMs in New Ad

Tina Carrasco, VP of Customer Partnership, The Craneware Group